Scarica l'app Stockscreener
8.65
0.70%
0.06
Precedente Chiudi:
$8.59
Aprire:
$8.59
Volume 24 ore:
190.24K
Relative Volume:
0.60
Capitalizzazione di mercato:
$310.15M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+10.90%
1M Prestazione:
+63.21%
6M Prestazione:
+121.79%
1 anno Prestazione:
-53.09%
Intervallo 1D:
$8.44
$8.99
Intervallo di 1 settimana:
$7.84
$8.99
Portata 52W:
$2.88
$20.37
Bioage Labs Inc Stock (BIOA) Company Profile
Nome
Bioage Labs Inc
Settore
Telefono
510-806-1445
Indirizzo
5885 HOLLIS STREET, EMERYVILLE
Confronta BIOA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
8.65 | 307.99M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-02-28 | Iniziato | William Blair | Mkt Perform |
| 2024-12-10 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-09 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-21 | Iniziato | Citigroup | Buy |
| 2024-10-21 | Iniziato | Jefferies | Buy |
| 2024-10-21 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioage Labs Inc Borsa (BIOA) Ultime notizie
Is BioAge Labs Inc a good long term investmentCapital Gains Strategies & Small Budget Portfolio Growth - earlytimes.in
BioAge stock craters 70% on obesity drug study halt (update) - MSN
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Is BioAge Labs Inc. stock recession proofStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Will BioAge Labs Inc. (Y7G) stock hit analyst forecastsBuy Signal & Expert Curated Trade Ideas - newser.com
Is BioAge Labs Inc. (Y7G) stock a buy on weakness2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
How interest rate cuts could boost BioAge Labs Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is BioAge Labs Inc. stock a buy before product launchesMarket Volume Report & Weekly Top Stock Performers List - newser.com
How supply shortages influence BioAge Labs Inc. (Y7G) stockWeekly Volume Report & Accurate Entry and Exit Point Alerts - newser.com
How to use Fibonacci retracement on BioAge Labs Inc.Gap Up & Verified Stock Trade Ideas - newser.com
Order flow analysis tools used on BioAge Labs Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Will BioAge Labs Inc. (Y7G) stock sustain uptrend momentumTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
How BioAge Labs Inc. (Y7G) stock stacks up against competitorsQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India
BIOA: NLRP3 inhibitor targets cardiovascular risk in obesity; APJ agonist INDs planned next year - TradingView
BioAge Labs (BIOA) Price Target Increased by 20.83% to 9.86 - Nasdaq
BioAge Labs Inc. stock trendline breakdownGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Bioage Labs Inc Azioni (BIOA) Dati Finanziari
Non sono disponibili dati finanziari per Bioage Labs Inc (BIOA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):